Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novilytic Wins SBIR Grant for Antibody Tech for Pharma Manufacturers | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novilytic Wins SBIR Grant for Antibody Tech for Pharma Manufacturers

$1.4 million contract will support research, development and commercialization of Novilytic’s new Proteometer.

By: Contract Pharma

Contract Pharma Staff

Novilytic LLC, a Purdue University-affiliated bio-analytics startup, has been awarded a Phase II SBIR contract by the National Institute of General Medical Sciences, one of the National Institutes of Health.

The $1.4 million Phase II contract will allow Novilytic to continue the research, development and commercialization of its new Proteometer. The new instrument technology is being created for process chemists and engineers who need to develop better process quality and control. The instrument is designed to test antibody purity in process.

The company will be opening new labs and hiring additional scientists in the coming months. Through the support of the Purdue Research Foundation and Purdue Foundry, Novilytic will continue to grow in the West Lafayette, IN area.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics